A20 inhibits lipopolysaccharide-induced inflammation in enterocytes.

Zheng, Cui-Fang; Shi, Jie-Ru; Huang, Ying; Wang, Sheng-Nan

Zheng, Cui-Fang; Shi, Jie-Ru; Huang, Ying; Wang, Sheng-Nan.

Afiliação

Zheng CF; Cui-Fang Zheng, Jie-Ru Shi, Ying Huang, Sheng-Nan Wang, Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai 201102, China.
Shi JR; Cui-Fang Zheng, Jie-Ru Shi, Ying Huang, Sheng-Nan Wang, Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai 201102, China.
Huang Y; Cui-Fang Zheng, Jie-Ru Shi, Ying Huang, Sheng-Nan Wang, Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai 201102, China.
Wang SN; Cui-Fang Zheng, Jie-Ru Shi, Ying Huang, Sheng-Nan Wang, Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai 201102, China.

World J Gastrointest Pharmacol Ther ; 7(4): 540-549, 2016 Nov 06.

Article em En | MEDLINE | ID: mdl-27867687

Palavras-chave

A20 (TNFAIP3); Inflammatory bowel disease; Lipopolysaccharide; Nuclear factor-κB

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Gastrointest Pharmacol Ther Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google